Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.

Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.

Item
http://www.wikidata.org/entity/Q33696563
Anti-platelet therapy: phosphodiesterase inhibitors.Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy AcPharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary interventionTargeting phosphodiesterases in anti-platelet therapyImprovement in in vitro fertilization outcome following in vivo synchronization of oocyte maturation in mice.Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.Consistency of drug-drug and gene-drug interaction information in US FDA-approved drug labels.Clopidogrel: a pharmacogenomic perspective on its use in coronary artery disease.Cilostazol improves hippocampus-dependent long-term memory in mice.Sex differences in pharmacokinetics of cilostazol in rats.
P2860

Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1.

Item
http://www.wikidata.org/entity/Q33696563
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@ast
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@en
type
label
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@ast
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@en
prefLabel
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@ast
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Population pharmacokinetic ana ...... of CYP3A5, CYP2C19 and ABCB1.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.2009.03558.X
P407
P433
P478
P577
P5875
P698
P932